82 related articles for article (PubMed ID: 12077277)
1. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation.
Ohta N; Hiroi T; Kweon MN; Kinoshita N; Jang MH; Mashimo T; Miyazaki J; Kiyono H
J Immunol; 2002 Jul; 169(1):460-8. PubMed ID: 12077277
[TBL] [Abstract][Full Text] [Related]
2. SLAMF4 Is a Negative Regulator of Expansion of Cytotoxic Intraepithelial CD8+ T Cells That Maintains Homeostasis in the Small Intestine.
O'Keeffe MS; Song JH; Liao G; De Calisto J; Halibozek PJ; Mora JR; Bhan AK; Wang N; Reinecker HC; Terhorst C
Gastroenterology; 2015 May; 148(5):991-1001.e4. PubMed ID: 25678452
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease.
Yokoyama S; Perera PY; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2013 Apr; 33(3):586-94. PubMed ID: 23269601
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase Otub1 controls the activation of CD8
Zhou X; Yu J; Cheng X; Zhao B; Manyam GC; Zhang L; Schluns K; Li P; Wang J; Sun SC
Nat Immunol; 2019 Jul; 20(7):879-889. PubMed ID: 31182807
[TBL] [Abstract][Full Text] [Related]
5. Enhanced natural killer activity and production of pro-inflammatory cytokines in mice selected for high acute inflammatory response (AIRmax).
Castoldi L; Golim MA; Filho OG; Romagnoli GG; Ibañez OC; Kaneno R
Immunology; 2007 Mar; 120(3):372-9. PubMed ID: 17163963
[TBL] [Abstract][Full Text] [Related]
6. Studying the cellular basis of small bowel enteropathy using high-parameter flow cytometry in mouse models of primary antibody deficiency.
Mohammed AD; Ball RAW; Jolly A; Nagarkatti P; Nagarkatti M; Kubinak JL
Front Immunol; 2024; 15():1278197. PubMed ID: 38803492
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory T cells-derived cytokines enhance the maturation of the human fetal intestinal epithelial barrier.
Giugliano FP; Navis M; Ouahoud S; Garcia TM; Kreulen IAM; Ferrantelli E; Meisner S; Vermeulen JLM; van Roest M; Billaud JN; Koster J; Dawood Y; de Bakker BS; Picavet-Havik DI; Schimmel IM; van der Wel NN; Koelink PJ; Wildenberg ME; Derikx JPM; de Jonge WJ; Renes IB; van Elburg RM; Muncan V
iScience; 2024 Jun; 27(6):109909. PubMed ID: 38812539
[TBL] [Abstract][Full Text] [Related]
8. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.
Meresse B; Chen Z; Ciszewski C; Tretiakova M; Bhagat G; Krausz TN; Raulet DH; Lanier LL; Groh V; Spies T; Ebert EC; Green PH; Jabri B
Immunity; 2004 Sep; 21(3):357-66. PubMed ID: 15357947
[TBL] [Abstract][Full Text] [Related]
9. Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases.
Wu WC; Shiu C; Tong TK; Leung SO; Hui CW
J Immunol Res; 2023; 2023():8924603. PubMed ID: 38106519
[TBL] [Abstract][Full Text] [Related]
10. A Mouse Model of Celiac Disease.
Abadie V; Khosla C; Jabri B
Curr Protoc; 2022 Aug; 2(8):e515. PubMed ID: 35994521
[TBL] [Abstract][Full Text] [Related]
11. Potent CCR3 Receptor Antagonist, SB328437, Suppresses Colonic Eosinophil Chemotaxis and Inflammation in the
Filippone RT; Dargahi N; Eri R; Uranga JA; Bornstein JC; Apostolopoulos V; Nurgali K
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887133
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis and environmental triggers in coeliac disease.
Levescot A; Malamut G; Cerf-Bensussan N
Gut; 2022 Jul; 71(11):2337-49. PubMed ID: 35879049
[TBL] [Abstract][Full Text] [Related]
13. IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes.
James OJ; Vandereyken M; Marchingo JM; Singh F; Bray SE; Wilson J; Love AG; Swamy M
Nat Commun; 2021 Jul; 12(1):4290. PubMed ID: 34257288
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease-on-chip: Modeling a multifactorial disease in vitro.
Moerkens R; Mooiweer J; Withoff S; Wijmenga C
United European Gastroenterol J; 2019 May; 7(4):467-476. PubMed ID: 31065364
[TBL] [Abstract][Full Text] [Related]
15. iNKT Cells Suppress Pathogenic NK1.1
Lee SW; Park HJ; Cheon JH; Wu L; Van Kaer L; Hong S
Front Immunol; 2018; 9():2168. PubMed ID: 30333822
[TBL] [Abstract][Full Text] [Related]
16. Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment.
Kasembeli MM; Bharadwaj U; Robinson P; Tweardy DJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081609
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of Human Anti-Interleukin-15 Antibody in Gluten-Sensitive Rhesus Macaques with Celiac Disease.
Sestak K; Dufour JP; Liu DX; Rout N; Alvarez X; Blanchard J; Faldas A; Laine DJ; Clarke AW; Doyle AG
Front Immunol; 2018; 9():1603. PubMed ID: 30050538
[TBL] [Abstract][Full Text] [Related]
18.
Park JY; Ligons DL; Park JH
Immune Netw; 2018 Feb; 18(1):e13. PubMed ID: 29503743
[TBL] [Abstract][Full Text] [Related]
19. Immunobiotic Lactobacillus strains reduce small intestinal injury induced by intraepithelial lymphocytes after Toll-like receptor 3 activation.
Tada A; Zelaya H; Clua P; Salva S; Alvarez S; Kitazawa H; Villena J
Inflamm Res; 2016 Oct; 65(10):771-83. PubMed ID: 27279272
[TBL] [Abstract][Full Text] [Related]
20. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.
Jabri B; Abadie V
Nat Rev Immunol; 2015 Dec; 15(12):771-83. PubMed ID: 26567920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
